AutoBlock® Fill is integrated with Masterflex® peristaltic pump.

Included software directs the AutoBlock Fill to dispense reagent as programmed by user. Reagent is dispensed via an integrated Masterflex® peristaltic pump accurate to ±2% volume and can be calibrated to any dispensing volume. The AutoBlock Fill can

Watson-Marlow Pumps Group Acquires Bio Pure Technology Limited

Bio Pure is a natural extension of the Watson-Marlow peristaltic pump range, complementing its offering in the Biopharmaceutical sector, and joining a portfolio comprising Watson-Marlow Pumps, Watson-Marlow Tubing, Flexicon Filling Systems, Alitea OEM

Watson-Marlow Fluid Technology Group Opens Office in Concord, Ontario to Provide Direct Support to Canadian Customers

As the world leader in niche peristaltic pump and associated fluid path technologies, Watson-Marlow Fluid Technology Group (WMFTG) continues to expand Flexicon aseptic filling and capping systems; ASEPCO aseptic valves; BioPure single-use connector

Positive Displacement Pumps - Global Market Outlook (2017-2023) - Research and Markets

The "Positive Displacement Pumps - Global Market Outlook (2017-2023)" report has been added to Research and Markets' offering. The Global Positive Displacement Pumps Market is valued at $3.32 billion in 2016 and is expected to reach $5.46 billion by 2023

Automatic Density Meter DS7800 from A.KRÜSS Optronic

A dry-air unit and a peristaltic pump for sample handling are included. Tubing material is also optionally available in a chemical resistant design. Injection filling, e.g. for higher viscosity specimens, is also possible.

Watson-Marlow Fluid Technology Group Acquires the Business of Flow Smart Inc.

WILMINGTON, MA -- (Marketwired) -- 11/25/15 -- Watson-Marlow Fluid Technology Group (WMFTG), the world leader in niche peristaltic pumps which includes Watson-Marlow Pumps, Watson-Marlow Tubing, Flexicon Filling Systems, BioPure single-use tubing

New technology and equipment for cereal, specialty crops

a metering conveyor and peristaltic metering pumps to ensure that the seed treatment is accurately applied. Because the seed treatment market continues to grow in North America the seed treater was developed to fill a void in precision on-farm seed

Building a morbidostat: an automated continuous-culture device for studying bacterial drug resistance under dynamically sustained drug inhibition

Construction of the morbidostat involves assembly of the morbidostat culture vials, assembly of the optical detection system and assembly of a computer-controlled array of peristaltic the pumps are turned off. The resulting growth curves (Fig.